1096 related articles for article (PubMed ID: 25639864)
21. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.
Paccagnella A; Ghi MG; Loreggian L; Buffoli A; Koussis H; Mione CA; Bonetti A; Campostrini F; Gardani G; Ardizzoia A; Dondi D; Guaraldi M; Cavallo R; Tomio L; Gava A;
Ann Oncol; 2010 Jul; 21(7):1515-1522. PubMed ID: 20032123
[TBL] [Abstract][Full Text] [Related]
22. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
Tobias JS; Monson K; Gupta N; Macdougall H; Glaholm J; Hutchison I; Kadalayil L; Hackshaw A;
Lancet Oncol; 2010 Jan; 11(1):66-74. PubMed ID: 19875337
[TBL] [Abstract][Full Text] [Related]
23. A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck.
Pinnarò P; Cercato MC; Giannarelli D; Carlini P; Del Vecchio MR; Impiombato FA; Marzetti F; Milella M; Cognetti F
Ann Oncol; 1994 Jul; 5(6):513-9. PubMed ID: 7918123
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
25. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
26. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.
Zhang H; Dziegielewski PT; Biron VL; Szudek J; Al-Qahatani KH; O'Connell DA; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Apr; 42(1):30. PubMed ID: 23672952
[TBL] [Abstract][Full Text] [Related]
27. Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Muzzi E; Trabalzini F; Gava A; Stellin M; Da Mosto MC
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1349-55. PubMed ID: 21258812
[TBL] [Abstract][Full Text] [Related]
28. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?
Paccagnella A; Mastromauro C; D'Amanzo P; Ghi MG
Oncologist; 2010; 15 Suppl 3():8-12. PubMed ID: 21036883
[TBL] [Abstract][Full Text] [Related]
29. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary results of a prospective randomized study of primary chemotherapy in carcinoma of the oral cavity and pharynx].
Volling P; Schröder M
HNO; 1995 Feb; 43(2):58-64. PubMed ID: 7713766
[TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
32. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
33. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
34. Functional organ preservation in patients with locoregionally advanced head and neck squamous cell carcinoma treated by platinum-based multidrug induction chemotherapy and concurrent chemoradiotherapy.
Boscolo-Rizzo P; Gava A; Marchiori C; Baggio V; Da Mosto MC
Ann Oncol; 2011 Aug; 22(8):1894-901. PubMed ID: 21273343
[TBL] [Abstract][Full Text] [Related]
35. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.
Lefebvre JL; Rolland F; Tesselaar M; Bardet E; Leemans CR; Geoffrois L; Hupperets P; Barzan L; de Raucourt D; Chevalier D; Licitra L; Lunghi F; Stupp R; Lacombe D; Bogaerts J; Horiot JC; Bernier J; Vermorken JB; ;
J Natl Cancer Inst; 2009 Feb; 101(3):142-52. PubMed ID: 19176454
[TBL] [Abstract][Full Text] [Related]
36. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
37. Low-dose preoperative chemoradiation therapy compared with surgery alone with or without postoperative radiotherapy in patients with head and neck carcinoma.
Mücke T; Konen M; Wagenpfeil S; Kesting MR; Wolff KD; Hölzle F
Ann Surg Oncol; 2011 Oct; 18(10):2739-47. PubMed ID: 21424882
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ; Murphy BA; Raez LE; Cohen RB; Spaulding M; Tishler RB; Roth B; Viroglio Rdel C; Venkatesan V; Romanov I; Agarwala S; Harter KW; Dugan M; Cmelak A; Markoe AM; Read PW; Steinbrenner L; Colevas AD; Norris CM; Haddad RI;
N Engl J Med; 2007 Oct; 357(17):1705-15. PubMed ID: 17960013
[TBL] [Abstract][Full Text] [Related]
39. nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma.
Adkins D; Ley J; Michel L; Wildes TM; Thorstad W; Gay HA; Daly M; Rich J; Paniello R; Uppaluri R; Jackson R; Trinkaus K; Nussenbaum B
Oral Oncol; 2016 Oct; 61():1-7. PubMed ID: 27688097
[TBL] [Abstract][Full Text] [Related]
40. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.
Lavertu P; Bonafede JP; Adelstein DJ; Saxton JP; Strome M; Wanamaker JR; Eliachar I; Wood BG
Arch Otolaryngol Head Neck Surg; 1998 Apr; 124(4):401-6. PubMed ID: 9559686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
